|
A more recent version of this article appeared on December 2, 2005
Papers In Press, published online ahead of print September 19, 2005
J. Biol. Chem, 10.1074/jbc.M509829200
Submitted on September 7, 2005
Accepted on September 19, 2005
Transactivation of CXCR4 by IGF-1R in human MDA-MB-231 breast cancer epithelial cells
Chareeporn Akekawatchai, Jane D. Holland, Marina Kochetkova, John C. Wallace, and Shaun R. McColl
Molecular & Biomedical Science, Adelaide University, Adelaide 5005
Corresponding Author: shaun.mccoll{at}adelaide.edu.au
In the multi-molecular environment in tissues and organs, cross-talk between growth factor and G protein-coupled receptors is likely to play an important role in both normal and pathological responses. In this report, we demonstrate transactivation of the chemokine receptor CXCR4 by the growth factor IGF-1 is required for IGF-1-induced cell migration in metastatic MDA-MB-231 cells. The induction of chemotaxis in MDA-MB-231 cells by IGF-1 was inhibited by pre-treatment of the cells with pertussis toxin (PTX) and by RNAi-mediated knockdown of CXCR4. Transactivation of the CXCR4 pathway by IGF-1 occurred independently of CXCL12, the chemokine ligand of CXCR4. Neither CXCR4 knockdown nor PTX had any effect on the ability of IGF-1 to activate IGF-1R, suggesting that CXCR4 and G-proteins are activated subsequent to, or independently of, phosphorylation of IGF-1R by IGF-1. Coprecipitation studies revealed the presence of a constitutive complex containing IGF-1R, CXCR4 and the G protein subunits, Gialpha2 and Gbeta, and stimulation of MDA-MB-231 cells with IGF-1 led to the release of Gialpha and Gbeta from CXCR4. Based on our findings, we propose that CXCR4 constitutively forms a complex with IGF-1R in MDA-MB-231 cells, and that this interaction allows IGF-1 to activate migrational signalling pathways through CXCR4, Gialpha2 and Gbeta.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
X. Sang, M. S. Curran, and A. W. Wood
Paracrine Insulin-Like Growth Factor Signaling Influences Primordial Germ Cell Migration: In Vivo Evidence from the Zebrafish Model
Endocrinology,
October 1, 2008;
149(10):
5035 - 5042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Jiang, A. Enomoto, M. Jijiwa, T. Kato, T. Hasegawa, M. Ishida, T. Sato, N. Asai, Y. Murakumo, and M. Takahashi
An Actin-Binding Protein Girdin Regulates the Motility of Breast Cancer Cells
Cancer Res.,
March 1, 2008;
68(5):
1310 - 1318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, L. Zhang, A. Qiao, K. Watson, J. Zhang, and G.-H. Fan
Activation of CXCR4 Triggers Ubiquitination and Down-regulation of Major Histocompatibility Complex Class I (MHC-I) on Epithelioid Carcinoma HeLa Cells
J. Biol. Chem.,
February 15, 2008;
283(7):
3951 - 3959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang, J.-M. Navenot, N. M. Frilot, N. Fujii, and S. C. Peiper
Association of Nucleophosmin Negatively Regulates CXCR4-Mediated G Protein Activation and Chemotaxis
Mol. Pharmacol.,
November 1, 2007;
72(5):
1310 - 1321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Gervasoni Jr., S. Sbayi, and B. Cady
Role of lymphadenectomy in surgical treatment of solid tumors: an update on the clinical data.
Ann. Surg. Oncol.,
September 1, 2007;
14(9):
2443 - 2462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. M. El-Shewy, K. R. Johnson, M.-H. Lee, A. A. Jaffa, L. M. Obeid, and L. M. Luttrell
Insulin-like Growth Factors Mediate Heterotrimeric G Protein-dependent ERK1/2 Activation by Transactivating Sphingosine 1-Phosphate Receptors
J. Biol. Chem.,
October 20, 2006;
281(42):
31399 - 31407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Holland, M. Kochetkova, C. Akekawatchai, M. Dottore, A. Lopez, and S. R. McColl
Differential functional activation of chemokine receptor CXCR4 is mediated by g proteins in breast cancer cells.
Cancer Res.,
April 15, 2006;
66(8):
4117 - 4124.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|